DCM

DAFNA Capital Management Portfolio holdings

AUM $431M
1-Year Est. Return 68.38%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+68.38%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$431M
AUM Growth
+$25.7M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
87
New
Increased
Reduced
Closed

Top Buys

1
+$8.92M
2
+$3.98M
3
+$2.93M
4
DNLI icon
Denali Therapeutics
DNLI
+$2.53M
5
MPLT
MapLight Therapeutics
MPLT
+$2.41M

Top Sells

1
+$20.8M
2
+$7.45M
3
+$6.53M
4
IBB icon
iShares Biotechnology ETF
IBB
+$5.59M
5
RCUS icon
Arcus Biosciences
RCUS
+$4M

Sector Composition

1 Healthcare 86.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RVMD icon
1
Revolution Medicines
RVMD
$19.7B
$48.1M 11.18%
604,514
-52,662
XBI icon
2
State Street SPDR S&P Biotech ETF
XBI
$8.13B
$41M 9.53%
336,505
-65,000
STXS icon
3
Stereotaxis
STXS
$202M
$31.5M 7.31%
13,680,554
ATRC icon
4
AtriCure
ATRC
$1.56B
$23.6M 5.49%
597,431
+5,158
CYTK icon
5
Cytokinetics
CYTK
$7.61B
$23.6M 5.48%
370,997
-23,943
IDYA icon
6
IDEAYA Biosciences
IDYA
$2.83B
$17.5M 4.07%
506,740
-33,183
AXGN icon
7
Axogen
AXGN
$1.59B
$15.6M 3.63%
476,826
-265,456
XENE icon
8
Xenon Pharmaceuticals
XENE
$3.34B
$12.9M 3%
287,939
IBB icon
9
iShares Biotechnology ETF
IBB
$8.58B
$11.5M 2.67%
68,095
-34,405
BHVN icon
10
Biohaven
BHVN
$1.53B
$10.8M 2.51%
955,235
+720,000
RCUS icon
11
Arcus Biosciences
RCUS
$2.52B
$10.3M 2.39%
431,329
-196,297
NBIX icon
12
Neurocrine Biosciences
NBIX
$13.3B
$10M 2.33%
70,615
DAWN icon
13
Day One Biopharmaceuticals
DAWN
$1.09B
$9.31M 2.16%
999,163
TNDM icon
14
Tandem Diabetes Care
TNDM
$1.72B
$7.81M 1.81%
355,208
ASND icon
15
Ascendis Pharma
ASND
$14.3B
$6.01M 1.4%
28,177
-5,000
DXCM icon
16
DexCom
DXCM
$28.3B
$5.86M 1.36%
88,279
+22,727
SNDX icon
17
Syndax Pharmaceuticals
SNDX
$1.89B
$5.84M 1.36%
277,855
-222,847
KALV icon
18
KalVista Pharmaceuticals
KALV
$823M
$5.76M 1.34%
356,802
-65,929
CMPS
19
Compass Pathways
CMPS
$783M
$5.6M 1.3%
811,046
INGN icon
20
Inogen
INGN
$166M
$5.56M 1.29%
827,071
+221,446
DNLI icon
21
Denali Therapeutics
DNLI
$3.31B
$5.26M 1.22%
318,500
+150,000
MBX
22
MBX Biosciences
MBX
$1.46B
$5.21M 1.21%
165,265
+80,265
BCAX
23
Bicara Therapeutics
BCAX
$919M
$4.4M 1.02%
261,583
-55,418
GLPG icon
24
Galapagos
GLPG
$2.22B
$4.26M 0.99%
130,175
ATXS
25
DELISTED
Astria Therapeutics
ATXS
$3.99M 0.93%
304,775
-15,000
1
2 3 4